Dr. Arrivo Was Fined 1.5 Million Yuan for Quality Problems
- Chaileedo Press
- Nov 18, 2022
- 2 min read
In the face of this 20 billion yuan market, the industry standards and market supervision related to beauty instruments need to be gradually improved.
Recently, according to many media reports, Walibao (Shanghai) Beauty Instrument Co., Ltd. was fined and confiscated more than 1.5 million yuan (2107500 dollars) for selling Dr. Arrivo Ghost PRIMIUM, which does not meet the national standards for protecting human health and personal and property safety.
Dr. Arrivo was founded in 2010 and officially entered the Chinese Mainland market in August 2018. CHAILEEDO learned that Dr. Arrivo participated in Tmall's Double 11 activity for the first time, which ranked the top 3 in the sales list of beauty salons, and still ranks the top 10 in the sales list of Tmall's Double 11 in this field. In addition, according to Mktindex data, Dr. Arrivo ranked No. 8 in the list of beauty and body care instruments with 2.1% of sales in this year's Tmall Double 11 event.
The unqualified product of Dr. Arrivo this time is the Phantom Beauty Instrument of its flagship brand series. According to public information, the Phantom of Zeus series beauty instrument was sold at the beginning of 2020 at a price of 6829 yuan (959.4 dollars).
Dr. Arrivo's official Tmall flagship store has 191,000 fans. Compared to other overseas flagship stores, Dr. Arrivo's official Tmall flagship store sells a small number of products, only one beauty instrument, Dr. Arrivo Zeus II, and a variety of skincare products. According to its Tmall flagship store, its main Dr. Arrivo Zeus II is priced at 9,888 yuan ($1,389.2), the same price as its overseas flagship store, while the rest of the several beauty instrument products sold in the overseas flagship store range from 2,500 yuan ($351.2) to 15,000 yuan ($2,108).
In both the overseas flagship store and the official Tmall flagship store, the above-mentioned Dr. Arrivo products involved in the case were not searched.
In addition, in March this year, the State Drug Administration issued an announcement clearly indicating that radiofrequency therapy instrument, and radiofrequency skin therapy instrument can be managed as three types of medical devices, the product according to the Medical Devices Registration Administration Method provisions to apply for registration. The announcement also pointed out that since April 1, 2024, radiofrequency therapy instrument, and radiofrequency skin therapy instrument products without medical device registration certificate according to law shall not be produced, imported and sold.
According to CHAIEEDO data, from 2014 to 2019, the average annual compound growth rate of China's beauty instrument market size reached 27%, and it is estimated that by 2026, China's household beauty instrument market size will exceed 20 billion yuan (2.81 billion dollars).
In the face of this 20 billion yuan market, the relevant industry standards and market supervision of beauty instruments need to be gradually improved, so that the household beauty instrument market can have greater growth and better development.
Comments